Consequenses of abnormal hemostasis tests for clinical practice

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 9, 2006, Pages 2062-2063

  Lisman, Ton ^a   Caldwell, S H ^b   Porte, R J ^c   Leebeek, F W G ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; FRESH FROZEN PLASMA;

BLEEDING TENDENCY; BLEEDING TIME; CLINICAL PRACTICE; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RISK BENEFIT ANALYSIS; SHORT SURVEY; THROMBOCYTOPENIA; TREATMENT INDICATION; BLOOD; BLOOD CLOTTING TEST; LIVER DISEASE; NOTE; PREDICTION AND FORECASTING; STANDARD;

BLOOD COAGULATION TESTS; HEMOSTASIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME;

EID: 33747169568     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02077.x     Document Type: Short Survey

References (19)

1. Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? Yes. J Thromb Haemost 2006; 4: 717-20.
2. Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? No. J Thromb Haemost 2006; 4: 721-3.
3. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: An evidence-based review. Transfusion 2005; 45: 1413-25.
4. O'Shaughnessy DF, Atterbury C, Bolton MP, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
5. Ramsey G. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: An evidence-based review. Best Pract Res Clin Haematol 2006; 19: 113-26.
6. Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: A dual phase study. Am J Gastroenterol 2003; 98: 1391-4.
7. Violi F, Leo R, Vezza E, Basili S, Cordova C, Balsano F. Bleeding time in patients with cirrhosis: Relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol 1994; 20: 531-6.
8. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1-20.
9. Basili S, Ferro D, Leo R, Juliano L, Alessandri C, Cordova C, Violi F. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. J Hepatol 1996; 24: 574-80.
10. Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 1999; 81: 378-81.
11. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
12. Mannucci PM, Vicente V, Vianello L, Cattaneo M, Alberca I, Coccato MP, Faioni E, Mari D. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148-53.
13. Cattaneo M, Tenconi PM, Alberca I, Garcia VV, Mannucci PM. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis. Thromb Haemost 1990; 64: 358-60.
14. Agnelli G, Parise P, Levi M, Cosmi B, Nenci GG. Effects of desmopressin on hemostasis in patients with liver cirrhosis. Haemostasis 1995; 25: 241-7.
15. de Franchis R, Arcidiacono PG, Carpinelli L, Andreoni B, Cestari L, Brunati S, Zambelli A, Battaglia G, Mannucci PM. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: A multicenter, double-blind study. New Italian Endoscopic Club. Hepatology 1993; 18: 1102-7.
16. Wong AY, Irwin MG, Hui TW, Fung SK, Fan ST, Ma ES. Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth 2003; 50: 14-20.
17. Pivalizza EG, Warters RD, Gebhard R. Desmopressin before liver transplantation. Can J Anaesth 2003; 50: 748-9.
18. Escolar G, Cases A, Vinas M, Pino M, Calls J, Cirera I, Ordinas A. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): Influence of hematocrit elevation. Haematologica 1999; 84: 614-9.
19. Pihusch R, Rank A, Gohring P, Pihusch M, Hiller E, Beuers U. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol 2002; 37: 548-55.